mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.3 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.3 |
mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.4 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.27 |
0.4 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |